全文获取类型
收费全文 | 73627篇 |
免费 | 4477篇 |
国内免费 | 279篇 |
专业分类
耳鼻咽喉 | 1165篇 |
儿科学 | 2104篇 |
妇产科学 | 1385篇 |
基础医学 | 8170篇 |
口腔科学 | 1550篇 |
临床医学 | 7242篇 |
内科学 | 15241篇 |
皮肤病学 | 1131篇 |
神经病学 | 7101篇 |
特种医学 | 2658篇 |
外国民族医学 | 5篇 |
外科学 | 12655篇 |
综合类 | 873篇 |
一般理论 | 95篇 |
预防医学 | 6023篇 |
眼科学 | 1444篇 |
药学 | 4650篇 |
中国医学 | 112篇 |
肿瘤学 | 4779篇 |
出版年
2023年 | 403篇 |
2022年 | 665篇 |
2021年 | 1793篇 |
2020年 | 942篇 |
2019年 | 1572篇 |
2018年 | 1840篇 |
2017年 | 1329篇 |
2016年 | 1364篇 |
2015年 | 1505篇 |
2014年 | 2321篇 |
2013年 | 3273篇 |
2012年 | 4925篇 |
2011年 | 5126篇 |
2010年 | 2806篇 |
2009年 | 2485篇 |
2008年 | 4526篇 |
2007年 | 4808篇 |
2006年 | 4647篇 |
2005年 | 4626篇 |
2004年 | 4368篇 |
2003年 | 4035篇 |
2002年 | 3727篇 |
2001年 | 616篇 |
2000年 | 549篇 |
1999年 | 698篇 |
1998年 | 767篇 |
1997年 | 684篇 |
1996年 | 609篇 |
1995年 | 541篇 |
1994年 | 524篇 |
1993年 | 442篇 |
1992年 | 454篇 |
1991年 | 413篇 |
1990年 | 357篇 |
1989年 | 349篇 |
1988年 | 332篇 |
1987年 | 323篇 |
1986年 | 327篇 |
1985年 | 428篇 |
1984年 | 473篇 |
1983年 | 408篇 |
1982年 | 563篇 |
1981年 | 523篇 |
1980年 | 476篇 |
1979年 | 239篇 |
1978年 | 302篇 |
1977年 | 285篇 |
1976年 | 237篇 |
1975年 | 248篇 |
1974年 | 229篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
951.
952.
953.
954.
955.
Joseph Jia Hong Toh Shanker Pasupathy Ruban A. L. Poopalalingam Mariko Siyue Koh 《Obesity surgery》2014,24(2):334-336
Obesity-associated severe asthma is a distinct phenotype characterised by resistance to standard asthma therapies. Bariatric surgery appears to be a viable alternative for those who have failed trials of traditional weight loss methods. However, anaesthetic and surgical risks are potential barriers. We describe three patients with treatment-resistant obesity-associated severe asthma who underwent bariatric surgery without complications due to the multidisciplinary perioperative planning and care involved in these complex cases. All three patients showed improvements in asthma control and reduction in maintenance medication use post-surgery. 相似文献
956.
957.
The fludarabine,cytarabine, and granulocyte colony‐stimulating factor (FLAG) chemotherapy regimen is an alternative to anthracycline‐based therapy for the treatment of acute myeloid leukemia for patients with pre‐existing cardiac disease 下载免费PDF全文
Lalit Saini Joseph Brandwein Robert Turner Loree Larratt Marlene Hamilton Anthea Peters Cynthia Wu Nancy Zhu Jeffery M. Patterson Lauren Bolster Michael Mant Bruce Ritchie Elena Liew Sunita Ghosh Irwindeep Sandhu 《European journal of haematology》2016,97(5):471-478
We conducted a retrospective study assessing FLAG (fludarabine, cytarabine, and granulocyte colony‐stimulating factor) as first‐line treatment in 56 newly diagnosed acute myeloid leukemia patients considered ineligible for anthracycline‐based treatment due to advanced age, significant comorbidities, or pre‐existing cardiac disease. The median age was 69 (21–80); 46% received FLAG for pre‐existing cardiac disease and others due to age (32%), non‐cardiac comorbidities (20%), or previous anthracycline exposure (2%). The induction mortality was 16% and, among evaluable patients, 48% achieved a complete remission after the first induction course with an additional patient achieving a remission after a second course for a total complete remission rate of 50%. Four patients proceeded to an allogeneic stem cell transplant including two with pre‐existing cardiac disease. Among non‐transplanted patients, the relapse rate (RR) was 47%. When censored at time of stem cell transplant, the median relapse‐free survival was 14.7 months. The median overall survival was 9.3 months with 1‐ and 2‐yr survivals of 44% and 22%, respectively. There was no difference in clinical outcomes between patients treated with FLAG for cardiac reasons vs. other reasons. In conclusion, FLAG is a useful alternative to anthracycline‐based induction for Acute myeloid leukemia in those with significant comorbidities including pre‐existing cardiac disease. 相似文献
958.
Margaret S. Herridge Marc Moss Catherine L. Hough Ramona O. Hopkins O. Joseph Bienvenu Elie Azoulay 《Intensive care medicine》2016,42(5):725-738
Outcomes after acute respiratory distress syndrome (ARDS) are similar to those of other survivors of critical illness and largely affect the nerve, muscle, and central nervous system but also include a constellation of varied physical devastations ranging from contractures and frozen joints to tooth loss and cosmesis. Compromised quality of life is related to a spectrum of impairment of physical, social, emotional, and neurocognitive function and to a much lesser extent discrete pulmonary disability. Intensive care unit-acquired weakness (ICUAW) is ubiquitous and includes contributions from both critical illness polyneuropathy and myopathy, and recovery from these lesions may be incomplete at 5 years after ICU discharge. Cognitive impairment in ARDS survivors ranges from 70 to 100 % at hospital discharge, 46 to 80 % at 1 year, and 20 % at 5 years, and mood disorders including depression and post-traumatic stress disorder (PTSD) are also sustained and prevalent. Robust multidisciplinary and longitudinal interventions that improve these outcomes are still uncertain and data in our literature are conflicting. Studies are needed in family members of ARDS survivors to better understand long-term outcomes of the post-ICU family syndrome and to evaluate how it affects patient recovery. 相似文献
959.
960.